NCT03597477View on ClinicalTrials.gov

Procedure Sedation With Dexmedetomidine in Children With Autism Spectrum Disorders During Magnetic Resonance Imaging

CompletedOBSERVATIONAL
Enrollment

136

Participants

Timeline

Start Date

July 16, 2018

Primary Completion Date

September 17, 2020

Study Completion Date

September 18, 2020

Conditions
Autism Spectrum Disorder
Interventions
DRUG

Dexmedetomidine

participants were randomly allocated to receive sedation with oral midazolam(0.3 mg/kg) combined with 4 doses of intranasal dexmedetomidine(1.0, 1.5, 2.0, 2.5)

Trial Locations (1)

510000

Guangzhou Women and Children Medical Center, Guangzhou

All Listed Sponsors
lead

Guangzhou Women and Children's Medical Center

OTHER

NCT03597477 - Procedure Sedation With Dexmedetomidine in Children With Autism Spectrum Disorders During Magnetic Resonance Imaging | Biotech Hunter | Biotech Hunter